Trump to announce deal with Pfizer to sell drugs at lower prices, Washington Post reports
U.S. President Donald Trump is set to announce a deal with Pfizer to sell medications at lower prices through Medicaid. This agreement aligns with the administration's push for drugmakers to match domestic prices with the lowest prices paid by high-income countries. In July, Trump sent letters to 17 drugmakers, including Pfizer, outlining price reduction expectations. Neither the White House nor Pfizer has commented on the report yet.
Sept 30 (Reuters) - U.S. President Donald Trump will announce an agreement with Pfizer (PFE.N) on Tuesday to voluntarily sell the company’s medications through Medicaid at lower prices, the Washington Post reported on Tuesday, citing sources.
The Trump administration has been pressing drugmakers to align domestic prices with the lowest levels paid by comparable high-income countries under the “most-favored-nation” policy.
Trump sent letters to
17 drugmakers
, including Pfizer, in July outlining how they should cut prices to match those paid overseas.
The White House and Pfizer did not immediately respond to Reuters’ requests for comment.
